KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -3.813 1 day ( 0 % )
Last Price $1.42 -8.34 %
High/ Low $1.42 - $1.43 -2.82%
Chg 7 Days -3.23 % $1.47 $1.42
Chg 30 Days -11.09 % $1.60 $1.42
Chg 12 mos 29.32 % $1.10 $1.42
Trend - 3 mos 45.29 % Width: 46.61 %
Trend - 12 mos -17.35 % Width: 447.46 %
Pred. range - 3 mos $2.07 - $3.03 45.28 % - 113.00 %
Pred. range - 12 mos $0.367 - $2.01 -74.21 % - 41.21 %
Short MA avg 3 mos Sell Apr 24, 2024 - 2 days
Long MA avg 3 mos Buy Apr 23, 2024 - 3 days
Short/Long MA avg 3 mos Sell Apr 12, 2024 - 10 days
Short MA avg 12 mos Buy Apr 23, 2024 - 3 days
Long MA avg 12 mos Sell Feb 16, 2024 - 48 days
Short/Long MA avg 12 mos Sell Mar 04, 2024 - 38 days
Pivot Short Sell Mar 11, 2024 - 33 days
Bollinger Buy Nov 30, -1 - N/A days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Interpace Diagnostics Group

Interpace Diagnostics Group Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians better assess risk of pancreaticobiliary cancers using its PathFinderTG platform; PanDNA, a molecular only version of PancraGEN that provides physicians a snapshot of a limited n... IDXG Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT